CHR-2797

CHR-2797 · Chroma Therapeutics

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CHR-2797, covering 2010-08-06 to 2012-06-28. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of the Safety and Effectiveness of CHR-2797 With Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer [Phase 1, Phase 2]

See pricing